Navigation Links
Eye Cell Implants Improve Parkinson's Symptoms

Small study found measurable gains in those with moderate to severe disease

MONDAY, April 28 (HealthDay News) -- By implanting specialized cells found in the human eye into areas of the brain damaged by Parkinson's disease, researchers were able to reduce symptoms and improve quality of life in people with moderate to severe Parkinson's.

The new treatment, dubbed Spheramine, reduced symptoms experienced when people were off their Parkinson's medications by 44 percent for as long as four years of follow-up. Quality-of-life measurements were up about 23 percent, according to the study, expected to be presented April 29 at the American Association of Neurological Surgeons' annual meeting, in Chicago.

"This is a promising study on a form of therapy that is different from anything out there," said the study's lead author, Dr. Roy Bakay, a professor of neurological surgery and the A. Watson and Sarah Armour Presidential Chair at Rush University Medical Center in Chicago.

"This therapy may be beneficial in itself, or it may be used as additional therapy," added Bakay, who was at Emory University in Atlanta at the time of the study.

Spheramine is made from cells called human retinal pigment epithelial cells (hRPE) that are found naturally in the human eye. By combining these cells with microscopic gelatin beads called microcarrier support matrix (MSM), the Emory researchers were able to produce Spheramine, a targeted therapy for Parkinson's. Spheramine can be implanted in the brain, where the eye cells naturally begin to produce levodopa. The researchers believe the levodopa is then turned into dopamine, a neurotransmitter lacking in people with Parkinson's.

"Spheramine is not stem cells. There's no requirement for immunosuppression, and these cells are easily harvested from eye banks and are readily available," Bakay said.

The new study included six patients with moderate to severe Parkinson's disease, a progressive brain disorder that causes tremors and other motor difficulties that worsen as the disease advances. Parkinson's affects as many 1.5 million Americans, according to background information in the study.

There are few effective treatments for Parkinson's, and those that do work often have unpleasant side effects and may stop working over time.

Patients selected for the study were chosen based on their responsiveness to levodopa and the severity of their symptoms when they were off their medication. Using MRI-guided stereotactic surgery, the researchers implanted Spheramine into areas of the volunteers' brains that appeared to be most affected by Parkinson's.

After 12 months, there was a 48 percent improvement in symptoms. At 48 months, that number had dropped to 44 percent, but Bakay said the researchers were pleased that the treatment maintained effectiveness for that long.

The only significant side effect seen in this small study was a transient headache, he said.

Dr. Bruce Silverman, a neurologist at Providence Hospital and Medical Center in Southfield, Mich., said the new study "showed that there was clinical improvement over a sustained period of time. The study was based on small numbers, but it shows some promise."

He added that the study needs to replicated with a larger group of patients.

Bakay said the researchers have recently completed a larger, double-blind study, and results of that trial should be available by the end of this year or early 2009.

More information

To learn more about treatments available for Parkinson's disease, visit the National Parkinson Foundation.

SOURCES: Roy Bakay, M.D., professor, neurological surgery, and the A. Watson and Sarah Armour Presidential Chair, Rush University Medical Center, Chicago; Bruce Silverman, D.O., neurologist, Providence Hospital and Medical Center, Southfield, Mich.; April 29, 2008, presentation, American Association of Neurological Surgeons' annual meeting, Chicago

Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Physicians Anticipate Changes in Their Usage of Hip Implants
2. UT Southwestern testing new hybrid hearing device combining advantages of hearing aids, implants
3. Boston Scientific Announces First European Implants of New Devices to Treat Heart Failure and Sudden Cardiac Death
4. Small-Diameter Dental Implants Increasingly Popular In the US
5. Porous structures help boost integration of host tissue with implants, study finds
6. Implants Double Infection Risk After Breast Reconstruction
7. Combined radiation seed, chemotherapy wafer implants show promise in treating cancerous brain tumors
8. Freeze-dried tendon implants prove effective in early studies
9. ASPS Studies Re-Evaluate Psychological Benefits and Health Concerns of Silicone Breast Implants
10. Neural Insights Could Bring Better Cochlear Implants
11. Advertisements for Medical Devices, Implants Should Carry Warnings of Dangerous Side Effects, Infections
Post Your Comments:
Related Image:
Eye Cell Implants Improve Parkinson's Symptoms
(Date:6/25/2016)... ... June 25, 2016 , ... ... and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes ... important health care topics including advance care planning, healthcare costs and patient and ...
(Date:6/25/2016)... ... , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his Bachelors ... Geffen School of Medicine at UCLA. He trained in Internal Medicine at Scripps Green ... hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to train ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events may ... to unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. To ... for healthy coping following a traumatic event. , Trauma sufferers tend to feel a ...
(Date:6/24/2016)... Francisco, CA (PRWEB) , ... June 24, 2016 ... ... CitiDent, is now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive ... self-ligating Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... proud to recognize Dr. Barry M. Weintraub as a prominent plastic surgeon and ... women in the world, and the most handsome men, look naturally attractive. Plastic ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... HILL, N.C. , June 24, 2016 /PRNewswire/ ... healthcare decisions and regulators/payers have placed more emphasis ... new environment, patient support programs in the pharmaceutical ... for patients, medications. Consequently, pharmaceutical companies are focusing ... ensure they are providing products and services that ...
(Date:6/24/2016)... , June 24, 2016  Global Blood ... biopharmaceutical company developing novel therapeutics for the treatment ... today announced the closing of its previously announced ... stock, at the public offering price of $18.75 ... offering were offered by GBT. GBT estimates net ...
(Date:6/24/2016)... June 24, 2016 ... announced the addition of the " Global Markets ... This report focuses ... an updated review, including its applications in various applications. ... market, which includes three main industries: pharmaceutical and biotechnology, ...
Breaking Medicine Technology: